Generex Biotechnology Corp (GNBTQ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 07/31
| 04-2016 | 01-2016 | 10-2015 | 07-2015 | 04-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -860 | -1,779 | -1,731 | -2,193 | -1,859 |
| Depreciation Amortization | 194 | 123 | 53 | 381 | 291 |
| Other Working Capital | 867 | 708 | 521 | -194 | -228 |
| Other Operating Activity | -899 | 249 | 461 | -878 | -467 |
| Operating Cash Flow | $-698 | $-698 | $-696 | $-2,885 | $-2,262 |
| Cash Flows From Investing Activities | |||||
| Purchase Sale Intangibles | N/A | N/A | N/A | -91 | -84 |
| Other Investing Activity | 0 | 0 | 0 | -91 | -84 |
| Investing Cash Flow | $N/A | $N/A | $N/A | $-91 | $-84 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 3 | 3 | 3 | 6 | 6 |
| Other Financing Activity | 0 | 0 | 0 | 475 | 0 |
| Financing Cash Flow | $3 | $3 | $3 | $481 | $6 |
| Exchange Rate Effect | -8 | -23 | -4 | -25 | -4 |
| Beginning Cash Position | 750 | 750 | 750 | 3,270 | 3,270 |
| End Cash Position | 47 | 32 | 52 | 750 | 926 |
| Net Cash Flow | $-703 | $-718 | $-698 | $-2,520 | $-2,344 |
| Free Cash Flow | |||||
| Operating Cash Flow | -698 | -698 | -696 | -2,885 | -2,262 |
| Free Cash Flow | -698 | -698 | -696 | -2,885 | -2,262 |